Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $31.8600 (-2.21%) ($31.0900 - $33.0500) on Thu. Apr. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 18 | Latest Price | $31.8600(-2.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.805% in a week (0% probabilities). UUP(-14%) VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
1 - 5 Day Possible Target | $22.34(-29.88%) | Resistance Level | $37.3 | 5 Day Moving Average | $34.3(-7.11%) | 10 Day Moving Average | $35.87(-11.18%) | 20 Day Moving Average | $37.3(-14.58%) | To recent high | -23.7% | To recent low | 0% | Market Cap | $2.367b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |